Pixium Vision

Développement d'une nouvelle génération de rétines artificielles destinées au traitement des cécités liées aux maladies de la dégénerescence rétinienne (réti...

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Paris, IDF, France
  • Currency EUR
  • Founded December 2011
  • Employees 15
  • Website pixium-vision.com

Company Summary

Développement d'une nouvelle génération de rétines artificielles destinées au traitement des cécités liées aux maladies de la dégénerescence rétinienne (rétinites pigmentaires en particulier)

Team

  • Bernard Jacques Gilly
    Chairman

    Former CEO Fovea Pharmaceuticals (sold to Sanofi). Former Partner at Sofinnova Partner. Former CEO Transgene

  • Robert Hill
    Chief Operating Officer

    Formerly Head of development IMI

  • Ralf Hornig
    Chief Medical Officer

    IMI

Advisors

  • Emmanuelle Porte (Nixon Peabody)
    Lawyer
    Unconfirmed

Previous Investors

  • Abingworth (UK)
    Unconfirmed
    Omnes Venture (France)
    Unconfirmed
    Polytechnos (germany)
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free